A new treatment option for raised seborrheic keratoses


eMediNexus    16 December 2017

The US Food and Drug Administration (FDA) has approved a high-concentration hydrogen peroxide topical solution (Eskata, Aclaris Therapeutics) for the treatment of raised seborrheic keratosis, which are noncancerous skin growths.

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.